These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 1831307)

  • 1. [The effect of endovascular helium-neon laser therapy on the immune status of patients with acute calculous pyelonephritis].
    Siniukhin VN; Ianenko EK; Safanov RM; Khamaganova EG; Borisik VI
    Urol Nefrol (Mosk); 1996; (6):9-11. PubMed ID: 9036617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [State of the cellular immunological reactivity in children with calculous pyelonephritis].
    Tagirov KKh; Utegenov N
    Urol Nefrol (Mosk); 1978; (1):30-3. PubMed ID: 628978
    [No Abstract]   [Full Text] [Related]  

  • 3. [Factor analysis of clinico-immunologic indicators in chronic calculous pyelonephritis].
    Popik GV; Kharitonov NN
    Urol Nefrol (Mosk); 1986; (2):15-20. PubMed ID: 3716027
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinicobiochemical and immunological assessment of polyoxidonium efficacy in the treatment of patients with chronic calculous pyelonephritis].
    Kazeko NI; Khil'kevich SV
    Urologiia; 2011; (6):20, 22-5. PubMed ID: 22448475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of laser radiation and sinusoidal modulated currents in the therapy of patients with chronic calculous pyelonephritis].
    Nesterov NI; Li AA; Vasil'eva MF; Slepushkina TG; Derevnina NA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1999; (4):24-5. PubMed ID: 10513467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immune status of patients with chronic calculous pyelonephritis and the possibilities for the correction of its disorders].
    LozinskiÄ­ MV; Zemskov AM; Chernov IuN
    Urol Nefrol (Mosk); 1991; (3):70-5. PubMed ID: 1831307
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mineral water Volzhanka from UndorovskÄ­ spring in combined therapy of patients with nephrolithiasis and chronic pyelonephritis].
    Pytel' IuA; Aliaev IuG; Rapoport LM; Rudenko VI
    Urologiia; 1999; (5):12-4. PubMed ID: 11150145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methods of eliminating immune complexes in kidney disease patients (a review of the literature)].
    Taran EI
    Vrach Delo; 1984 Aug; (8):61-6. PubMed ID: 6239451
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunopathological aspects of pyelonephritis in children].
    Zernov NG; Kirillov VI
    Urol Nefrol (Mosk); 1981; (2):60-6. PubMed ID: 6452730
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current problems in the pathogenesis of vasculitis in rheumatic diseases].
    Poltyrev AS
    Ter Arkh; 1990; 62(9):147-51. PubMed ID: 2149214
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic pyelonephritis: Pathogenesis, pathophysiology, and therapy].
    Tamaki K; Kusumoto T; Okuda S
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():485-8. PubMed ID: 16523939
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immune disturbances in acute pyelonephritis. Part I].
    Shatokhin MN; Konoplya AI; Kholimenko IM; Besprozvanniy VI; Mavrin MY
    Urologiia; 2019 Dec; (5):144-149. PubMed ID: 31808651
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.